Synaptogenix, Inc. (SNPX) Financials
SNPX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 32.4 million | 3.9 million |
2023-06-30 | 33.4 million | 6.5 million |
2023-03-31 | 36.5 million | 2.3 million |
2022-12-31 | 38.6 million | 3.2 million |
SNPX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -1.2 million | 15064 |
2023-06-30 | -1.2 million | 334416 |
2023-03-31 | -1.7 million | 644781 |
2022-12-31 | -2.8 million | 1.5 million |
SNPX Net Income
No data available :(
SNPX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 31.7 million | - | - |
2023-06-30 | 32.9 million | - | - |
2023-03-31 | 35.8 million | - | - |
2022-12-31 | 37.5 million | - | - |
SNPX Shares Outstanding
SNPX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 212103 | 1.2 million | - |
2023-06-30 | 669 | 307211 | 1.5 million | - |
2023-03-31 | 2038 | 877717 | 2.0 million | - |
2022-12-31 | 2139 | 1.4 million | 4.5 million | - |
SNPX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 1723 |
2023-06-30 | - | 1724 |
2023-03-31 | - | 1690 |
2022-12-31 | - | 1526 |
SNPX
Price: $4.53
52 week price:
Earnings Per Share: -29.50 USD
P/E Ratio: -0.19
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1967
Market Capitalization: 5.0 million